The Regional Health Contracting Office – Pacific, in support of Tripler Army Medical Center, Hawaii, intends to make a sole source award to BioFire Diagnostics, LLC for FDA approved, in-vitro diagnostic respiratory, blood culture identification, and meningitis/encephalitis panels with the use of a BioFire FilmArray Torch multiplex PCR instrument.  The period of performance is for a 12-month base period plus two 12-month options.  Respiratory panels shall include the following targets: Adenovirus, Coronavirus (HKU1, NL63, 229E, OC43), Metapneumovirus, Rhinovirus/Enterovirus, Influenza (A, A/H1, a/H3, A/H1-2009, B), Parainfluenza (1,2,3,4), RSV, Bordetella parapertussis, Bordetella pertussis, Chlamydia pneumoniae, Mycoplasma pneumoniae.   Blood culture panels shall include the following targets: Enterococcus, Listeria monocytogenes, Staphylococcus, Staphylococcus aureus, Streptococcus, Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes, Acinetobacter baumannii, Haemophilus influenza, Neisseria meningitidis, Pseudomonas aeruginosa, Enterobacteriaceae, Enterobacter cloacae complex, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Proteus, Serratia marcescens, Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis, Candida tropicalis, and resistance markers (mecA, vanA/B, KPC).  Meningitis/Encephalitis panels shall include the following targets: Escherichia coli, Haemophilus influenza, Listeria monocytogenes, Neisseria meningitidis, Streptococcus agalactiae, Streptococcus pneumoniae, CMV, EV, HSV-1, HSV-1, HHV-6, HPeV, and VZV. 

This announcement fulfills the synopsis requirements under FAR 5.201 and 5.203.  This Notice of Intent is not a request for competitive quotes.  All responsible sources may submit a capability statement, which shall be considered by the agency before the intended award date.  Information received in response to this notice will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government.  All questions and responses concerning this notice shall be emailed to donna.f.tomita.civ@ mail.mil.  The statutory authority permitting this award without providing full and open competition is FAR 13.501(a)(1)(ii) which authorizes the government to award contracts when there is only one responsible source and no other suppliers or services will satisfy agency requirements.

Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to supply the required products. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response.